COVID-19 tests have proven to be crucial in measuring the spread of the novel coronavirus (SARS-CoV-2) and helping us better understand how to navigate the current global pandemic. Testing has received a large amount of media attention in recent months, but the information has not always been clear. The most frequent misconception is that there … Continued
Since the Coronavirus pandemic began, we’ve been bombarded with endless and often competing information. In the ensuing months, the internet, and social media in particular, has been a place where many have gotten their news. Some of that information has been useful, while some of it has just been conspiracy theories and outright false claims. … Continued
Cell & Gene Therapy Insights Latest advances in CAR-T cell manufacture & clinical developments PHILIP H COELHO, Founder and Chief Technology Officer (CTO) of ThermoGenesis Corp., the device Division of Cesca Therapeutics (is an engineer/inventor, educated at the University of California, Davis, where he specialized in thermodynamics and machine design. He has been awarded more … Continued
In August, Novartis made history when its product Kymriah (tisagenlecleucel) became the first chimeric antigen receptor (CAR) T-cell therapy to win US approval. The product is made by collecting a patient’s cells through apheresis at a specialised clinic before shipping them to a manufacturing site where they are modified, expanded and tested. These are then … Continued
Chimeric antigen receptor T-cell receptor (CAR-T) and CAR-modified natural killer (CAR-NK) therapeutics can be produced faster and at less cost, Cesca Therapeutics says, through the cellular processing technology covered by a recently awarded patent. Cesca said Friday, July 28, 2017 that U.S. Patent No. 9,695,394, titled “Cell Separation Devices, Systems, and Methods,” has been awarded … Continued